MAGNETIC-RESONANCE SPECTROSCOPY DETECTS METABOLIC DIFFERENCES BETWEEN 7 DUNNING RAT PROSTATE TUMOR SUBLINES WITH DIFFERENT BIOLOGICAL BEHAVIOR

被引:11
作者
CORNEL, EB
HEERSCHAP, A
SMITS, GAHJ
OOSTERHOF, GON
DEBRUYNE, FMJ
SCHALKEN, JA
机构
[1] UNIV NIJMEGEN HOSP, DEPT UROL, 6500 HB NIJMEGEN, NETHERLANDS
[2] UNIV NIJMEGEN HOSP, DEPT RADIOL, 6500 HB NIJMEGEN, NETHERLANDS
关键词
P-31; MRS; H-1; DUNNING TUMOR MODEL SYSTEM; METABOLISM; PROSTATE CANCER;
D O I
10.1002/pros.2990250104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study, it was investigated whether prostate tumor biological parameters correlate with metabolic profiles. H-1 and P-31 magnetic resonance spectra were acquired from perchloric acid extracts of seven Dunning R-3327 prostate tumor sublines. Several metabolic ratios, for example, phosphocholine/total phosphate, choline/total creatine, and inositol/total creatine, did not correlate specifically with one biological characteristic-but, based on each of these ratios, the well-differentiated, nonmetastatic, and hormone-dependent sublines could be discriminated from the poorly differentiated or anaplastic, metastatic, and hormone-independent sublines. The glycerophosphoethanolamine/total phosphate, glycerophosphocholine/total phosphate, and phosphocreatine/total phosphate ratios correlated with differentiation grade, and the differences in glycerophosphorylglycerol/total phosphate ratio between metastatic and nonmetastatic sublines was highly significant. No correlation for hormonal sensitivity with any of the metabolites measured could be found, neither by P-31 nor by H-1 MRS. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 32 条
[1]   PROTON NUCLEAR MAGNETIC-RESONANCE OF INTACT FRIEND-LEUKEMIA CELLS - PHOSPHORYLCHOLINE INCREASE DURING DIFFERENTIATION [J].
AGRIS, PF ;
CAMPBELL, ID .
SCIENCE, 1982, 216 (4552) :1325-1327
[2]   RAT KIDNEY GLYCERYLPHOSPHORYLCHOLINE DIESTERASE [J].
BALDWIN, JJ ;
CORNATZER, WE .
BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 164 (02) :195-+
[3]   CANCER STATISTICS, 1991 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T .
CA-A CANCER JOURNAL FOR CLINICIANS, 1991, 41 (01) :19-36
[4]   PHOSPHORYLATED METABOLITES IN TUMORS, TISSUES, AND CELL-LINES [J].
BROWN, TR ;
GRAHAM, RA ;
SZWERGOLD, BS ;
THOMA, WJ ;
MEYER, RA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :229-240
[5]  
BUSSEMAKERS MJG, 1992, CANCER RES, V52, P2916
[6]   MODULATIONS OF GLYCEROPHOSPHORYLCHOLINE AND PHOSPHORYLCHOLINE IN FRIEND-ERYTHROLEUKEMIA CELLS UPON INVITRO-INDUCED ERYTHROID-DIFFERENTIATION - A P-31 NMR-STUDY [J].
CARPINELLI, G ;
PODO, F ;
DIVITO, M ;
PROIETTI, E ;
GESSANI, S ;
BELARDELLI, F .
FEBS LETTERS, 1984, 176 (01) :88-92
[7]  
COHEN JS, 1986, CANCER RES, V46, P4087
[8]  
CORBETT RJT, 1987, CANCER RES, V47, P5065
[9]   CHARACTERIZATION OF HUMAN PROSTATE-CANCER, BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE BY IN-VITRO H-1 AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY [J].
CORNEL, EB ;
SMITS, GAHJ ;
OOSTERHOF, GON ;
KARTHAUS, HFM ;
DEBRUYNE, FMJ ;
SCHALKEN, JA ;
HEERSCHAP, A .
JOURNAL OF UROLOGY, 1993, 150 (06) :2019-2024
[10]   CONCEPTS OF CITRATE PRODUCTION AND SECRETION BY PROSTATE .1. METABOLIC RELATIONSHIPS [J].
COSTELLO, LC ;
FRANKLIN, RB .
PROSTATE, 1991, 18 (01) :25-46